These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 17464421)
1. Combating oncogene activation associated with retrovirus-mediated gene therapy of X-linked severe combined immunodeficiency. Strauss BE; Costanzi-Strauss E Braz J Med Biol Res; 2007 May; 40(5):601-13. PubMed ID: 17464421 [TBL] [Abstract][Full Text] [Related]
2. A modified γ-retrovirus vector for X-linked severe combined immunodeficiency. Hacein-Bey-Abina S; Pai SY; Gaspar HB; Armant M; Berry CC; Blanche S; Bleesing J; Blondeau J; de Boer H; Buckland KF; Caccavelli L; Cros G; De Oliveira S; Fernández KS; Guo D; Harris CE; Hopkins G; Lehmann LE; Lim A; London WB; van der Loo JC; Malani N; Male F; Malik P; Marinovic MA; McNicol AM; Moshous D; Neven B; Oleastro M; Picard C; Ritz J; Rivat C; Schambach A; Shaw KL; Sherman EA; Silberstein LE; Six E; Touzot F; Tsytsykova A; Xu-Bayford J; Baum C; Bushman FD; Fischer A; Kohn DB; Filipovich AH; Notarangelo LD; Cavazzana M; Williams DA; Thrasher AJ N Engl J Med; 2014 Oct; 371(15):1407-17. PubMed ID: 25295500 [TBL] [Abstract][Full Text] [Related]
3. Curing genetic disease with gene therapy. Williams DA Trans Am Clin Climatol Assoc; 2014; 125():122-8; discussion 128-9. PubMed ID: 25125725 [TBL] [Abstract][Full Text] [Related]
4. The evolution of gene therapy in X-linked severe combined immunodeficiency. Rans TS; England R Ann Allergy Asthma Immunol; 2009 May; 102(5):357-62; quiz 363-5, 402. PubMed ID: 19492655 [TBL] [Abstract][Full Text] [Related]
5. Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency. Chinen J; Davis J; De Ravin SS; Hay BN; Hsu AP; Linton GF; Naumann N; Nomicos EY; Silvin C; Ulrick J; Whiting-Theobald NL; Malech HL; Puck JM Blood; 2007 Jul; 110(1):67-73. PubMed ID: 17369490 [TBL] [Abstract][Full Text] [Related]
6. Case of leukaemia associated with X-linked severe combined immunodeficiency gene therapy trial in London. Board of the European Society of Gene and Cell Therapy Hum Gene Ther; 2008 Jan; 19(1):3-4. PubMed ID: 18380015 [No Abstract] [Full Text] [Related]
7. New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy. Pike-Overzet K; van der Burg M; Wagemaker G; van Dongen JJ; Staal FJ Mol Ther; 2007 Nov; 15(11):1910-6. PubMed ID: 17726455 [TBL] [Abstract][Full Text] [Related]
8. Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vector. Horino S; Uchiyama T; So T; Nagashima H; Sun SL; Sato M; Asao A; Haji Y; Sasahara Y; Candotti F; Tsuchiya S; Kure S; Sugamura K; Ishii N PLoS One; 2013; 8(8):e71594. PubMed ID: 23990961 [TBL] [Abstract][Full Text] [Related]
9. Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand? Cavazzana M; Six E; Lagresle-Peyrou C; André-Schmutz I; Hacein-Bey-Abina S Hum Gene Ther; 2016 Feb; 27(2):108-16. PubMed ID: 26790362 [TBL] [Abstract][Full Text] [Related]
13. Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency. Thornhill SI; Schambach A; Howe SJ; Ulaganathan M; Grassman E; Williams D; Schiedlmeier B; Sebire NJ; Gaspar HB; Kinnon C; Baum C; Thrasher AJ Mol Ther; 2008 Mar; 16(3):590-8. PubMed ID: 18180772 [TBL] [Abstract][Full Text] [Related]
14. A novel model of SCID-X1 reconstitution reveals predisposition to retrovirus-induced lymphoma but no evidence of gammaC gene oncogenicity. Scobie L; Hector RD; Grant L; Bell M; Nielsen AA; Meikle S; Philbey A; Thrasher AJ; Cameron ER; Blyth K; Neil JC Mol Ther; 2009 Jun; 17(6):1031-8. PubMed ID: 19337236 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy for X-linked severe combined immunodeficiency: Historical outcomes and current status. Pai SY; Thrasher AJ J Allergy Clin Immunol; 2020 Aug; 146(2):258-261. PubMed ID: 32561390 [No Abstract] [Full Text] [Related]
16. Medical research: Gene-therapy reboot. Cassiday L Nature; 2014 May; 509(7502):651-3. PubMed ID: 24877176 [No Abstract] [Full Text] [Related]
17. Sola dosis facit venenum. Leukemia in gene therapy trials: a question of vectors, inserts and dosage? Staal FJ; Pike-Overzet K; Ng YY; van Dongen JJ Leukemia; 2008 Oct; 22(10):1849-52. PubMed ID: 18769449 [TBL] [Abstract][Full Text] [Related]
18. Occurrence of leukaemia following gene therapy of X-linked SCID. Kohn DB; Sadelain M; Glorioso JC Nat Rev Cancer; 2003 Jul; 3(7):477-88. PubMed ID: 12835668 [TBL] [Abstract][Full Text] [Related]
19. Retrovirus-induced oncogenesis and safety of retroviral vectors. Nair V Curr Opin Mol Ther; 2008 Oct; 10(5):431-8. PubMed ID: 18830918 [TBL] [Abstract][Full Text] [Related]
20. New Gene Therapy Potential Cure for "Bubble Boy Disease": An experimental gene therapy has allowed children with SCID-1X to develop fully functioning immune systems. Am J Med Genet A; 2019 Jul; 179(7):1114-1115. PubMed ID: 31180192 [No Abstract] [Full Text] [Related] [Next] [New Search]